LCN2 and glomerulosclerosis: Moreover, those diabetic animals receiving Φ‐NGAL treatment were the only group displaying a significant reduction in glomerulosclerosis as well as collagen IV and fibronectin glomerular deposition compared to D+SHAM and its control group D+Φ‐RAW mice (Figure 2A‐D).